Quick Takeaways
- Richard Scott Struthers has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $58,407,741.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Richard Scott Struthers
- Location
- San Diego, CA
- Summary
- The estimated net worth of Richard Scott Struthers is at least $58,407,741 dollars as of 18 Mar 2026. Richard Scott Struthers is the President & CEO, Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $58.41M.
- Signature
- /s/ Tobin Schilke, as attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Richard Scott Struthers and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Crinetics Pharmaceuticals, Inc. ($58,407,741).
- Past-year value change for that position: -$1,001,513.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Richard Scott Struthers
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | President & CEO, Director | $58,407,741 | -$1,001,513 | -1.7% | 16 Mar 2026 |
Insider Transactions Reported by Richard Scott Struthers:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.